HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Klaus T Preissner Selected Research

Ribonucleases (Ribonuclease)

11/2015RNase1 as a potential mediator of remote ischaemic preconditioning for cardioprotection†.
7/2013Internalization of Bacillus intermedius ribonuclease (BINASE) induces human alveolar adenocarcinoma cell death.
12/2009New directions in inflammation and immunity: the multi-functional role of the extracellular RNA/RNase system.
2/2009RNase therapy assessed by magnetic resonance imaging reduces cerebral edema and infarction size in acute stroke.
10/2007Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor.
4/2007Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Klaus T Preissner Research Topics

Disease

14Inflammation
12/2015 - 02/2003
12Neoplasms (Cancer)
05/2015 - 06/2002
10Neointima
08/2015 - 03/2003
10Thrombosis (Thrombus)
04/2014 - 03/2003
8Atherosclerosis
02/2014 - 03/2003
6Vascular Diseases (Vascular Disease)
03/2014 - 12/2004
6Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
08/2011 - 07/2007
5Anoxia (Hypoxia)
12/2015 - 08/2004
5Idiopathic Pulmonary Fibrosis
08/2013 - 09/2008
4Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
12/2015 - 08/2005
4Necrosis
11/2015 - 02/2009
4Vascular System Injuries
08/2015 - 06/2003
4Fibrosis (Cirrhosis)
08/2013 - 11/2005
4Infection
08/2013 - 06/2003
4Stroke (Strokes)
08/2010 - 10/2007
4Brain Edema (Cerebral Edema)
12/2009 - 07/2007
3Neuroblastoma
12/2015 - 12/2005
3Myocardial Infarction
11/2015 - 11/2002
3Ischemia
03/2015 - 07/2007
3Atherosclerotic Plaque (Atheroma)
10/2014 - 03/2006
3Hyperglycemia
03/2010 - 01/2006
2Wounds and Injuries (Trauma)
03/2015 - 02/2007
2Venous Thrombosis (Deep-Vein Thrombosis)
04/2014 - 01/2014
2Pulmonary Hypertension (Ayerza Syndrome)
01/2014 - 01/2012
2Chronic Obstructive Pulmonary Disease (COPD)
10/2013 - 01/2012
2Pulmonary Fibrosis (Hamman Rich Syndrome)
08/2013 - 01/2012
2Thrombocytopenia (Thrombopenia)
07/2013 - 08/2004
2Liver Cirrhosis (Hepatic Cirrhosis)
06/2009 - 05/2009
2Cardiovascular Diseases (Cardiovascular Disease)
06/2009 - 12/2006
2Interstitial Lung Diseases (Interstitial Lung Disease)
12/2008 - 03/2008
2Carcinoma (Carcinomatosis)
07/2007 - 11/2002
2Neoplasm Metastasis (Metastasis)
05/2007 - 02/2003
2Carotid Stenosis (Carotid Artery Stenosis)
12/2006 - 04/2004
2Retinal Neovascularization
12/2005 - 08/2004
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2016
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
12/2015
1Acute Coronary Syndrome
03/2015
1Endometriosis (Adenomyosis)
12/2014
1Venous Thromboembolism
04/2014
1Aortic Aneurysm (Aneurysm, Aortic)
04/2014
1Communicable Diseases (Infectious Diseases)
03/2014
1Fatigue
12/2013
1Fasciculation (Fasciculations)
10/2013

Drug/Important Bio-Agent (IBA)

12RNA (Ribonucleic Acid)IBA
11/2015 - 02/2005
9Factor VII (Proconvertin)IBA
06/2009 - 04/2004
7Proteins (Proteins, Gene)IBA
12/2013 - 08/2005
6Ribonucleases (Ribonuclease)IBA
11/2015 - 04/2007
6glucuronyl glucosamine glycan sulfate (Vessel)IBA
04/2014 - 08/2004
4AntibodiesIBA
12/2015 - 12/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013 - 12/2005
4platelet-derived growth factor BB (becaplermin)FDA Link
05/2009 - 12/2006
4FibrinIBA
12/2008 - 04/2007
3Immunoglobulin G (IgG)IBA
12/2015 - 12/2005
3Messenger RNA (mRNA)IBA
12/2015 - 08/2004
3ThrombinFDA Link
03/2015 - 08/2013
3Deoxyribonucleases (DNase)IBA
08/2013 - 04/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2013 - 08/2004
3Thromboplastin (Tissue Factor)IBA
11/2012 - 02/2005
3Serine Proteases (Serine Protease)IBA
08/2010 - 04/2004
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2008 - 11/2002
3AutoantibodiesIBA
11/2007 - 08/2005
3Plasminogen Activators (Plasminogen Activator)IBA
07/2007 - 06/2002
2Nucleic AcidsIBA
12/2015 - 08/2008
2IntegrinsIBA
08/2015 - 02/2007
2DNA (Deoxyribonucleic Acid)IBA
12/2014 - 10/2012
2indium-bleomycinIBA
08/2013 - 09/2008
2Heparin (Liquaemin)FDA LinkGeneric
07/2013 - 03/2008
2Factor XII (Hageman Factor)IBA
04/2012 - 04/2010
2Factor VIIa (Activated Factor VII)IBA
06/2011 - 03/2008
2Glycoproteins (Glycoprotein)IBA
06/2011 - 04/2002
2VitronectinIBA
06/2011 - 12/2004
2Carbon MonoxideIBA
04/2010 - 03/2003
2adhesion receptorIBA
02/2007 - 06/2003
2OsteoprotegerinIBA
04/2006 - 08/2004
2Retinaldehyde (Retinal)IBA
12/2005 - 08/2004
2alpha-DefensinsIBA
12/2005 - 08/2004
1Biological Markers (Surrogate Marker)IBA
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2015
1human VEGFA proteinIBA
12/2015
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2015
1Neuropilin-1IBA
12/2015
1High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
08/2015
1FibrinolysinFDA Link
05/2015
1Arginine (L-Arginine)FDA Link
03/2015
1SYTOX Orange dyeIBA
12/2014
1cadherin 5IBA
04/2014
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2014
1Phosphotransferases (Kinase)IBA
04/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2014
1Apolipoproteins E (ApoE)IBA
02/2014
1ApolipoproteinsIBA
02/2014
1PhospholipidsIBA
01/2014
1Adenosine Triphosphatases (ATPase)IBA
12/2013
1PlasticsIBA
10/2013
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
10/2013
1polysialic acidIBA
10/2013

Therapy/Procedure

1Thrombectomy
03/2015
1Endarterectomy (Thromboendarterectomy)
04/2014
1Splenectomy
01/2014